Yervoy

Report: Roche's Zelboraf, BMS' Yervoy control their segment
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
Flag link:
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Seeking Alpha
Zelboraf
Yervoy
melanoma
GSK
Bristol-Myers Squibb
Roche
Flag link:
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows
Bloomberg
melanoma
Bristol-Myers Squibb
radiation therapy
Yervoy
Flag link:
Bristol-Myers' Post-Patent Plan
Bristol-Myers' Post-Patent Plan
Motley Fool
patents
Bristol-Myers Squibb
Plavix
Sanofi
Yervoy
liscensing
M&A
Flag link:
Two Top Biotech Plays With Safe Upside
Two Top Biotech Plays With Safe Upside
Seeking Alpha
ImmunoCellular
glioblastoma multiforme
brain cancer
Bristol-Myers Squibb
Yervoy
melanoma
Flag link:
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
UK
Yervoy
Bristol-Myers Squibb
NICE
skin cancer
Flag link:
Yervoy may face Roche rival sooner than expected
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Bristol-Myers Squibb
Zelboraf
melanoma
Yervoy
Roche
Flag link:
Yervoy hits the market with $95M bang
Yervoy hits the market with $95M bang
Fierce Pharma
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Bristol-Myers Squibb
Dapagliflozin
Pfizer
Eli Lilly
AstraZeneca
JNJ
Yervoy
Flag link:
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Yahoo/BusinessWire
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
Roche, Bristol Melanoma Drugs Shine
Roche, Bristol Melanoma Drugs Shine
The Street
Roche
Bristol-Myers Squibb
melanoma
vemurafenib
Yervoy
Flag link:
Bristol-Myers, Roche team up on melanoma drugs
Bristol-Myers, Roche team up on melanoma drugs
Yahoo/AP
Roche
Bristol-Myers Squibb
melanoma
Yervoy
vermurafenib
Flag link:
Melanoma Set to Be a Hot Topic at ASCO
Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
ASCO
melanoma
skin cancer
Yervoy
Bristol-Myers Squibb
Daiichi Sankyo
Roche
Flag link:
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
Flag link:
The Big Winner of the EU Drug Approval Bonanza
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Flag link:
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Yervoy
Provenge
Dendreon
Bristol-Myers Squibb
melanoma
prostate cancer
Flag link:
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Seeking Alpha
ipilimumab
Bristol-Myers Squibb
Yervoy
Flag link:
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Minyanville
FDA
Bristol-Myers Squibb
Yervoy
ipilimumab
melanoma
Flag link:
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
ipilimumab
monoclonal antibodies
immunotherapy
Yervoy
Bristol-Myers Squibb
melanoma
Flag link:
[video] The Next Big Thing In Biotech: Bristol-Myers
[video] The Next Big Thing In Biotech: Bristol-Myers
TheStreet.com
Bristol-Myers Squibb
skin cancer
Yervoy
ipilimumab
Flag link:

Pages